PAUL RODENBIKER: Open Payments
NPI 1629639919 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 9 payments from 7 companies in 2025. Trend: 2023 $63 · 2024 $223 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| Lundbeck LLC | 2 | $35 |
| TG Therapeutics, Inc. | 1 | $31 |
| UCB, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
Products named: Leqembi, VYEPTI, BRIUMVI, Briviact, AJOVY, AUSTEDO XR, WAINUA, QULIPTA.
Industry payments across ND — which companies pay providers there.
